Invention Grant
- Patent Title: Sustained-release formulations of topiramate
-
Application No.: US13595103Application Date: 2012-08-27
-
Publication No.: US08663683B2Publication Date: 2014-03-04
- Inventor: Likan Liang , Hua Wang , Padmanabh P. Bhatt , Michael L. Vieira
- Applicant: Likan Liang , Hua Wang , Padmanabh P. Bhatt , Michael L. Vieira
- Applicant Address: US MD Rockville
- Assignee: Supernus Pharmaceuticals, Inc.
- Current Assignee: Supernus Pharmaceuticals, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Foley & Lardner LLP
- Agent Stephen B. Maebius; Sunit Talapatra
- Main IPC: A61K31/35
- IPC: A61K31/35 ; A61K9/24 ; A61K9/54 ; A61P3/10 ; A61P25/02 ; A61P25/06

Abstract:
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
Public/Granted literature
- US20120321708A1 SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE Public/Granted day:2012-12-20
Information query